New Delhi, Dec 17: Dr Reddy’s Laboratories on Saturday said its subsidiary DRRDBV has entered into a pact to sell certain assets and liabilities of its Netherlands-based site. Dr Reddy’s Research and Development B V (DRRDBV), a wholly-owned subsidiary of the Hyderabad-based company, has entered into an asset purchase agreement with Delpharm Development Leiden BV, part of France-based Delpharm Group, the drug firm said in a regulatory filing. The agreement includes sale of its certain assets and liabilities including transfer […]